Jazz Pharmaceuticals (JAZZ) Q2 2023 Earnings

9AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.07
1.68
3.42
5.17

Details

Expected EPS
4.43
Actual EPS
4.51
Surprise EPS
0.08
Surprise Percent
+1.81%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of 4.51 per share for Q2 2023.

0 Comments

Share your thoughts